Carcinogenesis Advance Access originally published online on June 25, 2008
Carcinogenesis 2008 29(8):1546-1554; doi:10.1093/carcin/bgn146
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells
1 Department of Microbiology and Immunology
2 Department of Morphology
3 Department of Physiology, Faculty of Health Sciences, Ben-Gurion University Cancer Research Center, Ben-Gurion University of the Negev, PO Box 653, Beer-Sheva 84105, Israel
* To whom correspondence should be addressed. Tel: +972 8 6477250; Fax: +972 8 6477626; Email: dmitrif{at}bgu.ac.il
Failure of current therapeutic modalities to treat melanoma remains a challenge for clinical and experimental oncology. The aggressive growth and apoptotic resistance of this tumor are mediated, in part, by aberrantly activated protein kinase B/Akt (PKB). In many cells, PKB signaling depends on integrity of cholesterol-enriched membrane microdomains (rafts). However, it is still unclear if rafts support deregulated PKB activity in melanoma. In this study, ablation of rafts in murine (B16BL6-8, JB/RH1) and human (GA) melanoma lines by cholesterol-chelating methyl-β-cyclodextrin (MβCD) reduced levels of constitutively active PKB in a dose- and time-dependent manner, while reconstitution of microdomains restored PKB activity. PKB was sensitive to the membrane-permeable Ca2+ chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N'N'-tetraacetic acid tetra (acetocymethyl) ester and to the calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-naphtalenesulfonamide (W7) implying the contribution of Ca2+ signaling to PKB deregulation. Indeed, malignant and apoptosis-resistant clone of B16BL6 melanoma (B16BL6-8) displayed significantly higher [Ca2+]i and store-operated Ca2+ influx (SOC) relative to non-malignant apoptosis-sensitive B16BL6 clone (Kb30) expressing barely detectable basal levels of active PKB. Raft ablation in B16BL6-8 cells robustly inhibited SOC and decreased [Ca2+]i to levels comparable with those detected in Kb30 cells. Treating cells by PKB-inhibiting doses of MβCD dramatically impaired their apoptotic resistance and capacity to generate tumors. Furthermore, weekly intraperitoneal injections of MβCD to mice grafted with melanoma cells at doses of 300 and 800 mg/kg significantly attenuated tumor development. Our data implicate membrane rafts in enhancing the resistance of melanoma to apoptosis and indicate that targeting raft microdomains is a potentially effective strategy to cure this frequently fatal form of cancer.
Abbreviations: BAPTA-AM, 1,2-bis(o-aminophenoxy)ethane-N,N,N'N'-tetraacetic acid tetra (acetocymethyl) ester; MβCD, methyl-β-cyclodextrin; PBS, phosphate-buffered saline; PKB, protein kinase B; SOC, store-operated Ca2+ influx; XTT, 2,3-bis(2-methoxy-4-nitro-5-sulfoneyl)-2H-tetrasolium-5-carboxanilide
Received December 9, 2007; revised May 19, 2008; accepted June 13, 2008.